Free tool
FAERS Monitor: Flonase Sensimist Allergy Relief
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 022051 or its brand name (Flonase Sensimist Allergy Relief, Fluticasone Furoate). Reports on generic versions are filed under their own applications.
Reports
8,316
Serious
5,747
69% of reports
Hospitalization
2,271
Death reported
526
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective1,637
- dyspnoea1,043
- off label use879
- asthma863
- nausea631
- wheezing624
- pain621
- macular degeneration614
- therapeutic product effect incomplete570
- headache568
- cough563
- vomiting547
- product use in unapproved indication544
- malaise527
- condition aggravated456
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2007 | 1 |
| 2008 | 4 |
| 2009 | 3 |
| 2010 | 17 |
| 2011 | 52 |
| 2012 | 266 |
| 2013 | 41 |
| 2014 | 76 |
| 2015 | 96 |
| 2016 | 96 |
| 2017 | 553 |
| 2018 | 582 |
| 2019 | 576 |
| 2020 | 561 |
| 2021 | 1,070 |
| 2022 | 993 |
| 2023 | 1,042 |
| 2024 | 906 |
| 2025 | 818 |
| 2026 | 563 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,045,843 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| macular degenerationSignal | 614 | 137.0 | 126.7 | 78,555 |
| wheezingSignal | 624 | 26.9 | 24.9 | 15,406 |
| therapeutic product effect incompleteSignal | 570 | 20.4 | 18.9 | 10,460 |
| asthmaSignal | 863 | 19.5 | 18.3 | 15,055 |
| product use in unapproved indicationSignal | 544 | 5.6 | 5.1 | 2,050 |
| coughSignal | 563 | 5.1 | 4.7 | 1,865 |
| dyspnoeaSignal | 1,043 | 4.7 | 4.4 | 3,079 |
| condition aggravatedSignal | 456 | 3.8 | 3.5 | 949 |
| drug ineffectiveSignal | 1,637 | 3.1 | 3.0 | 2,548 |
| malaiseSignal | 527 | 3.0 | 2.8 | 735 |
| vomitingSignal | 547 | 2.9 | 2.7 | 716 |
| painSignal | 621 | 2.6 | 2.4 | 605 |
| off label useSignal | 879 | 2.5 | 2.4 | 854 |
| headacheSignal | 568 | 2.3 | 2.1 | 425 |
| nauseaSignal | 631 | 2.0 | 1.9 | 335 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.